MET@Learning APAC Live Webinar:
Focus on METex14 in Advanced NSCLC
Release date: 21-10-2024
Expiration date: 21-10-2025
Optimizing biomarker detection for METex14 skipping in advanced NSCLC
Helena A. Yu, MD
Memorial Sloan Kettering Cancer Center
New York, USA
-
Optimizing biomarker detection for METex14 skipping in advanced NSCLC
Helena A. Yu, MD
-
Evolving treatment options for METex14 skipping: Where are we now?
Tang Hao, MD, PhD
-
Panel Discussion: Optimal strategies for biomarker testing and treatment selection in METex14 skipping
Myung-Ju Ahn, MD, PhD
-
How I treat 1L patients with METex14 skipping
Jii Bum (Joy) Lee, MD, PhD
-
How I treat perioperative patients with METex14 skipping
Minjiang Chen, MD, PhD
-
Moving forward with MET inhibitors: Embarking on an expedition for the future
Nick Pavlakis, MBBS, MMEd (Clin Epi), PhD
-
Panel Discussion: Treatment decision-making in clinical practice and the evolving landscape
Baohui Han, MD, PhD